GWP42003-P (cannabidiol)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GWP42003-P (cannabidiol), covering 2020-07-23 to 2020-07-23. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7) [Phase 3]